Mapping of the auto-inhibitory interactions of protein kinase R by nuclear magnetic resonance

被引:31
作者
Gelev, Vladimir
Aktas, Huseyin
Marintchev, Assen
Ito, Takuhiro
Frueh, Dominique
Hemond, Michael
Rovnyak, David
Debus, Mirijam
Hyberts, Sven
Usheva, Anny
Halperin, Jose
Wagner, Gerhard
机构
[1] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Lab Membrane Transport, Cambridge, MA 02139 USA
[3] Bucknell Univ, Dept Chem, Lewisburg, PA 17837 USA
[4] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA
关键词
PKR; NMR; kinase; eIF2; alpha; RNA-binding domain;
D O I
10.1016/j.jmb.2006.08.077
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The dsRNA-dependent protein kinase (PKR) is a key mediator of the antiviral and anti-proliferative effects of interferon. Unphosphorylated PKR is characterized by inhibitory interactions between the kinase and RNA binding domains (RBDs), but the structural details of the latent state and its unraveling during activation are not well understood. To study PKR regulation by NMR we assigned a large portion of the backbone resonances of the catalytically inactive K296R kinase domain, and performed N-15-heteronuclear sin le quantum coherence (HSQC) titrations; of this kinase domain with the RBDs. Chemical shift perturbations in the kinase indicate that RBD2 binds to the substrate eIF2 alpha docking site in the kinase C-lobe. Consistent with these results, a mutation in the eIF2 alpha docking site, F495A, displays weaker interactions with the RBD. The full-length RBD1 + 2 binds more strongly to the kinase domain than RBD2 alone. The observed chemical shift changes extend from the eIF2 alpha binding site into the kinase N-lobe and inside the active site, consistent with weak interactions between the N-terminal part of the RBD and the kinase. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:352 / 363
页数:12
相关论文
共 46 条
[1]   THE CONSERVED LYSINE OF THE CATALYTIC DOMAIN OF PROTEIN-KINASES IS ACTIVELY INVOLVED IN THE PHOSPHOTRANSFER REACTION AND NOT REQUIRED FOR ANCHORING ATP [J].
CARRERA, AC ;
ALEXANDROV, K ;
ROBERTS, TM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (02) :442-446
[2]   Targets and mechanisms for the regulation of translation in malignant transformation [J].
Clemens, MJ .
ONCOGENE, 2004, 23 (18) :3180-3188
[3]  
DACQUISTO F, 2001, SCI STKE, pRE1
[4]   Higher-order substrate recognition of elF2α by the RNA-dependent protein kinase PKR [J].
Dar, AC ;
Dever, TE ;
Sicheri, F .
CELL, 2005, 122 (06) :887-900
[5]   NMRPIPE - A MULTIDIMENSIONAL SPECTRAL PROCESSING SYSTEM BASED ON UNIX PIPES [J].
DELAGLIO, F ;
GRZESIEK, S ;
VUISTER, GW ;
ZHU, G ;
PFEIFER, J ;
BAX, A .
JOURNAL OF BIOMOLECULAR NMR, 1995, 6 (03) :277-293
[6]   Mechanistic link between PKR dimerization, autophosphorylation, and elF2α substrate recognition [J].
Dey, M ;
Cao, C ;
Dar, AC ;
Tamura, T ;
Ozato, K ;
Sicheri, F ;
Dever, TE .
CELL, 2005, 122 (06) :901-913
[7]   Identification of the heparin-binding domains of the interferon-induced protein kinase, PKR [J].
Fasciano, S ;
Hutchins, B ;
Handy, I ;
Patel, RC .
FEBS JOURNAL, 2005, 272 (06) :1425-1439
[8]  
GALABRU J, 1987, J BIOL CHEM, V262, P15538
[9]   Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferon-induced protein kinase [J].
Gale, M ;
Katze, MG .
PHARMACOLOGY & THERAPEUTICS, 1998, 78 (01) :29-46
[10]   Characterization of the heparin-mediated activation of PKR, the interferon-inducible RNA-dependent protein kinase [J].
George, CX ;
Thomis, DC ;
McCormack, SJ ;
Svahn, CM ;
Samuel, CE .
VIROLOGY, 1996, 221 (01) :180-188